New Review of Rociletinib-An Investigational Therapy in Patients With Previously Treated EGFR Mutant-positive Non-small Cell Lung Cancer Google+ Share with LinkedIn r
LONDON, December 22, 2015 /PRNewswire/ —
Oncology & Hematology Review, the peer-reviewed journal, has published a review highlighting recent data around rociletinib, an investigational therapy in patients with previously treated EGFR mutant-positive non-small cell lung cancer.